Learn more about AVALIDE for patients who need added efficacy to achieve their BP goals.

Once-daily superior DBP-reducing power vs losartan at maximum once-daily doses.^18,19
See study designs and results.

Tools to Help Your Patients Get to Their BP Goals

The JNC 7 guidelines recommend that patients receive specific information designed to help them modify their lifestyle and to take medications as prescribed, in order to reach their BP goals and reduce associated risks.¹

Here are some tools that you can print out and share with your patients to help them stay with your prescribed therapy.

To view and print out the files below, you must have Adobe Acrobat Reader installed on your computer.

Personal Blood Pressure Tracker

This handy chart can help your appropriate patients with hypertension record blood pressure readings. It includes space for the date, time, systolic blood pressure and diastolic blood pressure, along with things to keep in mind when taking their blood pressure. Download the Personal Blood Pressure Tracker now following the full Prescribing Information.

Patient Brochure

This short brochure, written in patient-friendly language, helps explain the benefits of AVAPRO or AVALIDE and the need for proper diet and activity. Download the patient brochure now following the full Prescribing Information.

A Helping of Healthy Meals

Eating right and maintaining the weight recommended by you may help your patients reduce blood pressure. This short brochure describes appropriate ways of eating, tips for an ideal meal plan, and how to become more active. Download A Helping of Healthy Meals now.

WARNING: USE IN PREGNANCY When pregnancy is detected, discontinue AVAPRO or AVALIDE as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. [See Warnings and Precautions: Fetal/Neonatal Morbidity and Mortality in the full Prescribing Information.]

Please see Indications and Important Safety Information.